Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Darzalex (daratumumab) for the Treatment of Multiple Myeloma

Drug (Brand / Generic)

Darzalex / daratumumab

Company / Licensee

Genmab / Janssen Biotech

Product Description

Monoclonal antibody (mAb)

Current Indication

Multiple Myeloma

Market Sector

Oncology

Development Status

Approved in the US, NDS under review in Canada
Expand

Go Top